Presentation at the International Thrombosis and Haemostasis Issues in Cancer Conference, Stresa Italy
Despite travel interruptions due to volcanic ash, the International Thrombosis and Haemostasis Issues in Cancer Conference went ahead at Stresa Italy. TRAD Alliance medical director Anthony Maraveyas gave an oral presentation on “Gemcitabine with or without prophylactic weight-adjusted dalteparin (WAD) in patients with advanced or metastatic pancreatic cancer (APC): a multi centre, randomised phase IIB trial (the UK FRAGEM study)”.
Also, a poster presentation titled “Filling the evidence gap in palliative care: a qualitative study to identify the research agenda for thromboprophylaxis in advanced cancer” by S.I.R. Noble, A. Nelson, I.G. Finlay was presented on behalf of the TRAD Alliance.
An abstract of the poster can be viewed from the following link (will open in a new window):